CanaryIQ uses privacy-friendly, cookieless analytics (Fathom) to understand aggregate site usage. We don't use tracking cookies, we don't sell or share your data, and we respect Global Privacy Control. See our Privacy Policy.

Spatial biology

Spatial biology tools can now measure more things together. 10x markets RNA and protein analysis in the same cell, alongside larger targeted gene panels. These are different test set-ups, and suppliers are still competing on resolution. Clinical use will need evidence beyond a supplier's specifications for its research platform.

medium conviction emerging

Research snapshot · updated Nov 12, 2026

Core thesis

Spatial biology maps which genes are active in a tissue section and where in the tissue they are active. That helps researchers understand how tumours interact with the cells around them and how drugs work. Resolution varies by product. Standard 10x Genomics Visium captures RNA in spots 55 micrometres across, which usually cover several cells. Visium HD uses a grid of 2-micrometre squares, small enough to work at the scale of single cells. 10x also now sells analysis of RNA and protein in the same cell, and larger targeted gene panels. Use in clinical practice is at an early stage.

State of the art (2026)

Spatial biology in 2026 is a 10x Genomics-led market consolidating fast. At AACR in April 2026 10x unveiled Atera, a whole-transcriptome in situ platform it calls its most significant launch ever, shipping in the second half of the year and stacking on top of Xenium Prime 5K and Visium HD. The challengers have been absorbed rather than beaten: Bruker now runs the former NanoString CosMx and GeoMx lines and shipped a CosMx whole-transcriptome panel, while Quanterix acquired Akoya, folding PhenoCycler proteomics into a tissue-plus-blood biomarker play. The open question is no longer resolution or plex — those are largely solved — but whether spatial earns a reimbursed clinical role rather than staying a pharma and academic research tool.

Explore the deeper analysis in CanaryIQ

Explore what is covered below. These previews show the structure; log in to read the full analysis.

Signal stack

Evidence stacked leading → lagging

9 signals
talent
research
patent
expert
operational
regulatory
market

Technology-native KPIs

Metrics that predict trajectory, tracked over time

4 tracked
Installed platform base
Clinical spatial assays in development
Spatial biology market size
Spatial transcriptomics publications

Landscape map

Who builds what, and who depends on whom

54 players · 6 layers

Catalyst calendar

Dated events that will move the position

3 ahead

Technology roadmap

Milestones on the path to maturity

8 milestones

Watchlists

Companies, people and papers, each with a condition for removing it

20 · 20
Companies · 20
People · 20

Decision frameworks

What our view means for your job

Locked
Public Equity
PE / VC
Corporate Leader

Thesis changelog

When our view changed, and why

8 updates

Change our mind

3 disconfirming conditions

You've read the verdict. The file is much deeper.

The full signal stack, technology-native KPIs tracked over time, the landscape of who depends on whom, the dated catalyst calendar, decision frameworks for every desk, live watchlists and a record of every time our view on Spatial biology has changed. All of it is in CanaryIQ.